Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Reata Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President, Chief Research & Development Officer
Reata Pharmaceuticals, a global biopharmaceutical company focused on developing and commercializing novel therapies for patients […]
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease
HanAll Biopharma and Daewoong Pharmaceutical announced that they have entered into a co-development agreement with NurrOn […]
CPC Launches Biopharma's Largest Aseptic Connectors, AseptiQuik W Series
CPC (Colder Products Company), part of Dover and a leading manufacturer of connection technologies used […]
PharmaVentures Establishes an Office in Seoul to Enhance Access for South Korean Biotechs
PharmaVentures announces its new office in South Korea as part of its continued strategic expansion. […]
Neochromosome and Sumitovant Biopharma Announce Successful Collaboration to Accelerate Protein Drug Discovery and Improve Manufacturing
Neochromosome, a wholly owned subsidiary of Opentrons Labworks, focused on changing the world of biologics […]
Asieris Appoints Dr. Linda Wu as Chief Development Officer
Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for […]
BioSpace Names Most Promising New Biopharma Companies to Watch in 2023
BioSpace, the leading life sciences news and careers site, has announced its 2023 selections for […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more